Quarterly report · Q2
4005.TEDINET S100PHEX
Period2022-04-01 → 2022-09-30
Filed2022-11-08
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 59
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.53T | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥754.4bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥2.77T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.33T | 2021-04-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥686.2bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥60.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | −¥5.7bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥144.3bn | 2021-04-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥85.9bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥126.8bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥13.1bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥251.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥146.8bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥90.1bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥81.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥11.1bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥162.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥88.9bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥53.2bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥73.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | −¥12.0bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥186.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥107.8bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥68.9bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥4.68T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥4.31T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥4.08T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥2.79T | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.61T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.89T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.70T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.55T | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.48T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.38T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.22T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.08T | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥486.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥365.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥346.8bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥360.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥83.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥171.7bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥77.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | ¥15.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥115.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥65.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥24.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥81.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥27.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥49.58 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥6.77 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥99.16 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥54.36 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥32.55 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥49.57 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥6.77 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 29.5% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 28.3% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.5% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 124
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥79.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-07-01 → 2022-09-30 | ¥47.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥37.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-07-01 → 2022-09-30 | ¥23.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥42.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥24.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-07-01 → 2022-09-30 | −¥708m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥57.6bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥32.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥57.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥32.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥11.6bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥4.1bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥183.7bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥92.4bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥173.5bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥87.1bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥10.1bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥5.3bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥6.8bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥470.4bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥230.3bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥467.3bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥228.7bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥23.3bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥13.3bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥295.9bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥142.4bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥293.9bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥141.3bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥36.3bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥14.4bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥222.4bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥107.7bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥222.2bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥107.5bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥234m |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥118m |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥26.4bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥10.7bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥334.5bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥166.7bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥334.4bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥166.7bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7m |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥1m |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥25.2bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥11.1bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.51T |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥739.5bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.49T |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥731.4bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥15.5bn |
| —segment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥8.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥124.7bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥56.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥59.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-07-01 → 2021-09-30 | ¥31.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥30.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-07-01 → 2021-09-30 | ¥17.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥29.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥14.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥6.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-07-01 → 2021-09-30 | ¥4.0bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥41.3bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-09-30 | −¥20.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥41.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-09-30 | −¥20.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥10.4bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥5.4bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥154.5bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥77.1bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥148.5bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥74.1bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥12.6bn |
| jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥5.9bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥402.1bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥201.4bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥399.5bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥200.0bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥42.0bn |
| jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥18.2bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥212.8bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥107.3bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥209.4bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥106.4bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥955m |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥18.5bn |
| jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥8.2bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥227.9bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥118.5bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥227.7bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥118.4bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥226m |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥116m |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥16.0bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥309.6bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥170.4bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥309.6bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥170.4bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥9m |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥7m |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥50.0bn |
| jpcrp040300-q2r_E00752-000Medical Productsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥40.3bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.31T |
| —segment total | revenue | 2021-07-01 → 2021-09-30 | ¥674.7bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.29T |
| —segment total | revenue external | 2021-07-01 → 2021-09-30 | ¥669.2bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥12.2bn |
| —segment total | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥5.5bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥152.6bn |
| —segment total | segment profit | 2021-07-01 → 2021-09-30 | ¥88.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 994
| Item | Context | Value | Unit |
|---|---|---|---|
| Finance income IFRS | Prior1QuarterDuration | 8718000000 | JPY |
| Finance income IFRS | CurrentQuarterDuration | 29835000000 | JPY |
| Finance costs IFRS | Prior1QuarterDuration | 4558000000 | JPY |
| Finance costs IFRS | CurrentQuarterDuration | 10998000000 | JPY |
| Profit loss before tax IFRS | Prior1QuarterDuration | 90088000000 | JPY |
| Profit loss before tax IFRS | CurrentQuarterDuration | 13122000000 | JPY |
| Income tax expense IFRS | Prior1QuarterDuration | 21162000000 | JPY |
| Income tax expense IFRS | CurrentQuarterDuration | 25168000000 | JPY |
| Profit loss IFRS | Prior1QuarterDuration | 68926000000 | JPY |
| Profit loss IFRS | CurrentQuarterDuration | -12046000000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1QuarterDuration | 53225000000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentQuarterDuration | 11071000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | Prior1QuarterDuration | 15701000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | CurrentQuarterDuration | -23117000000 | JPY |
| Profit loss IFRS | Prior1QuarterDuration | 68926000000 | JPY |
| Profit loss IFRS | CurrentQuarterDuration | -12046000000 | JPY |
| Basic earnings loss per share IFRS | Prior1QuarterDuration | 32.55 | |
| Basic earnings loss per share IFRS | CurrentQuarterDuration | 6.77 | |
| Diluted earnings loss per share IFRS | Prior1QuarterDuration | － | |
| Diluted earnings loss per share IFRS | CurrentQuarterDuration | 6.77 | |
| Profit loss IFRS | Prior1YTDDuration | 107810000000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | 73062000000 | JPY |
| Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRS | Prior1YTDDuration | -35696000000 | JPY |
| Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRS | CurrentYTDDuration | -13651000000 | JPY |
| Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRS | Prior1YTDDuration | -74000000 | JPY |
| Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRS | CurrentYTDDuration | -83000000 | JPY |
| Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRS | Prior1YTDDuration | 287000000 | JPY |
| Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRS | CurrentYTDDuration | -848000000 | JPY |
| Total of items that will not be reclassified to profit or loss oci IFRS | Prior1YTDDuration | -35483000000 | JPY |
| Total of items that will not be reclassified to profit or loss oci IFRS | CurrentYTDDuration | -14582000000 | JPY |
| Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRS | Prior1YTDDuration | -2467000000 | JPY |
| Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRS | CurrentYTDDuration | 9807000000 | JPY |
| Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRS | Prior1YTDDuration | 6328000000 | JPY |
| Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRS | CurrentYTDDuration | 119029000000 | JPY |
| Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRS | Prior1YTDDuration | 6129000000 | JPY |
| Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRS | CurrentYTDDuration | 28044000000 | JPY |
| Total of items that may be reclassified to profit or loss oci IFRS | Prior1YTDDuration | 9990000000 | JPY |
| Total of items that may be reclassified to profit or loss oci IFRS | CurrentYTDDuration | 156880000000 | JPY |
| Other comprehensive income IFRS | Prior1YTDDuration | -25493000000 | JPY |
| Other comprehensive income IFRS | CurrentYTDDuration | 142298000000 | JPY |
| Comprehensive income IFRS | Prior1YTDDuration | 82317000000 | JPY |
| Comprehensive income IFRS | CurrentYTDDuration | 215360000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS | Prior1YTDDuration | 76757000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS | CurrentYTDDuration | 183577000000 | JPY |
| Comprehensive income attributable to non controlling interests IFRS | Prior1YTDDuration | 5560000000 | JPY |
| Comprehensive income attributable to non controlling interests IFRS | CurrentYTDDuration | 31783000000 | JPY |
| Comprehensive income IFRS | Prior1YTDDuration | 82317000000 | JPY |
| Comprehensive income IFRS | CurrentYTDDuration | 215360000000 | JPY |
| Profit loss IFRS | Prior1QuarterDuration | 68926000000 | JPY |
| Profit loss IFRS | CurrentQuarterDuration | -12046000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |